What Is a Sessile Serrated Lesion and Why Does It Matter?

Answer in brief: A sessile serrated lesion (SSL) is a usually flat or subtly elevated colorectal polyp, often in the proximal colon, that can progress to cancer through the serrated neoplasia pathway. SSLs matter because they are easy to miss, can be incompletely resected, and may progress through molecular pathways distinct from conventional adenomas. Size, dysplasia, lesion number and resection completeness determine surveillance intensity.

Key clinical points

SSLs are often pale, flat, mucus-capped and located in the right colon.
Careful inspection and excellent bowel preparation are essential for detection.
One to two SSLs <10 mm generally permit longer surveillance; larger, more numerous, dysplastic or traditional serrated lesions require earlier follow-up.
Piecemeal resection of a large SSL requires an early site check.

Recognition

SSLs can blend into surrounding mucosa. Typical clues include a mucus cap, indistinct borders, cloud-like surface, interruption of the normal vascular pattern, and a subtle change in mucosal contour. Withdrawal technique, washing and adequate distension are therefore central to detection.

Biology

The serrated pathway is associated with molecular alterations including BRAF mutation and CpG island methylation; some lesions progress toward mismatch-repair deficiency. Clinically, this pathway helps explain why some interval colorectal cancers arise in the proximal colon despite prior colonoscopy.

Resection

Because margins are often indistinct, incomplete removal is a particular concern. Cold-snare techniques are effective for many small lesions; larger lesions require deliberate advanced-resection planning. Tattooing should be placed appropriately when referral is required and should not interfere with subsequent resection.

Surveillance

U.S. Multi-Society Task Force guidance recommends approximately 5–10 years after 1–2 SSLs <10 mm, 3–5 years after 3–4 small SSLs, and about 3 years for 5–10 SSLs, an SSL ≥10 mm, an SSL with dysplasia, or a traditional serrated adenoma. Piecemeal resection of an SSL ≥20 mm generally requires surveillance at about 6 months. These intervals assume a high-quality complete examination and confident complete resection.

Practical approach

1. Confirm a high-quality baseline colonoscopy and complete resection.

2. Classify lesion by size, number, histology and serrated versus adenomatous pathway.

3. Use the shortest guideline interval driven by the highest-risk finding.

4. Refer technically difficult benign lesions for advanced endoscopic resection rather than repeated biopsy.

Common errors to avoid

Using histology without considering resection completeness and baseline colonoscopy quality.
Treating all serrated lesions as low-risk hyperplastic polyps.

Trainee takeaway

A sessile serrated lesion (SSL) is a usually flat or subtly elevated colorectal polyp, often in the proximal colon, that can progress to cancer through the serrated neoplasia pathway. The examination question is usually less about memorizing one cutoff than recognizing which finding changes the next clinical decision.

Relevant free books by Dr. Alan B. R. Thomson

Thomson ABR. Endoscopy and Diagnostic Imaging, Parts I–II. CAPstone Academic Publishers; 2012.
Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014. ISBN 978-1500855321.

Free downloads: https://giandhepatology.com/free-medical-books-on-gastroenterology-and-hepatology

Frequently asked questions

Is an SSL the same as a hyperplastic polyp?

No. Small distal hyperplastic polyps generally have very low malignant potential, whereas SSLs are recognized precursors in the serrated pathway.

Why are SSLs missed?

They are often flat, pale and mucus-covered, particularly in the right colon. Inadequate cleansing and rapid withdrawal make detection substantially harder.

References

1. Thomson ABR. Endoscopy and Diagnostic Imaging, Parts I–II. CAPstone Academic Publishers; 2012.

2. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014. ISBN 978-1500855321.

3. Gupta S, Lieberman D, Anderson JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020;158:1131-1153.

4. Kaltenbach T, Anderson JC, Burke CA, et al. Endoscopic removal of colorectal lesions: recommendations by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2020;91:486-519.

Editorial note: This educational article synthesizes Dr. Thomson’s teaching framework with current society guidance. Recommendations should be checked against the latest guideline, local formulary, regulatory labeling and the individual clinical context before patient-specific use.